Patent · US Active

Melanocortin-1 receptor-specific cyclic peptides

US9447148B2 · kind B2 · utility

3Cited by
38References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 15, 2014
Grant dateSep 20, 2016
Priority date
Expiry dateDec 9, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Melanocortin receptor-specific cyclic peptides of the formulawhere R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined in the specification, compositions and formulations including the peptides of the foregoing formula or salts thereof, and methods of preventing, ameliorating or treating melanocortin-1 receptor-mediated or responsive diseases, indications, conditions and syndromes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.